|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/62 | (2006.01) |
| C07K 14/55 | (2006.01) | ||
| C07K 14/715 | (2006.01) |
| (11) | Number of the document | 3401402 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18162555.9 |
| Date of filing the European patent application | 2013-06-06 | |
| (97) | Date of publication of the European application | 2018-11-14 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-14 |
| (46) | Date of publication of the claims translation | 2020-12-28 |
| (30) | Number | Date | Country code |
| 201261657378 P | 2012-06-08 | US | |
| 201261657264 P | 2012-06-08 | US | |
| 201261657285 P | 2012-06-08 | US | |
| 201261723081 P | 2012-11-06 | US | |
| 201361778575 P | 2013-03-13 | US | |
| 201361778812 P | 2013-03-13 | US |
| (72) |
ALVAREZ, Juan, US
CHAMOUN, Jean, US
|
| (73) |
Alkermes Pharma Ireland Limited,
Connaught House 1 Burlington Road, Dublin 4,
IE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Ligandai, modifikuoti cirkuliarinės permutacijos pagalba, kaip agonistai ir antagonistai |
| LIGANDS MODIFIED BY CIRCULAR PERMUTATION AS AGONISTS AND ANTAGONISTS |
| Payment date | Validity (years) | Amount | |
| 2025-06-04 | 13 | 289.00 EUR |
| 2026-06-06 |